Skip to main content
79°
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Elanco Animal Health Inc
(NY:
ELAN
)
12.70
-0.02 (-0.16%)
Streaming Delayed Price
Updated: 12:39 PM EDT, Jul 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Elanco Animal Health Inc
< Previous
1
2
3
Next >
Zoetis, Pet-Med Specialist, Double-Digit Earnings Growth Ahead
February 16, 2023
Animal health company Zoetis is up 7.99% in the past week, after topping fourth-quarter views. Analysts see double-digit EPS growth in 2023 and 2024.
Via
MarketBeat
Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2022 Financial Results Announcement
February 03, 2023
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco to Participate in the 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco Announces FDA Approval of Bexacat™ (bexagliflozin tablets) – the First-of-its-Kind Oral Feline Diabetes Treatment Option
December 09, 2022
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco to Participate in Evercore ISI 5th Annual HealthCONx Conference
November 16, 2022
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco Animal Health Reports Third Quarter 2022 Results
November 08, 2022
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco Confirms Date and Conference Call for Third Quarter 2022 Financial Results Announcement
October 11, 2022
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco Announces Changes to its Board of Directors
September 08, 2022
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco to Participate in Morgan Stanley 20th Annual Global Healthcare Conference
September 01, 2022
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco Releases 2021 Environmental, Social and Governance Report Highlighting Progress on Healthy Purpose™ Goals
August 16, 2022
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco Animal Health Reports Second Quarter 2022 Results
August 08, 2022
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco Confirms Date and Conference Call for Second Quarter 2022 Financial Results Announcement
July 18, 2022
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco Survey Finds Many Pets Live Unprotected Against Preventable Diseases
July 12, 2022
From
Elanco Animal Health Incorporated
Via
Business Wire
New Anthem from Seresto Could be the 2022 Song of the Summer
June 07, 2022
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference
June 06, 2022
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco to Participate in Stifel 2022 Jaws and Paws Conference
May 23, 2022
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco Animal Health Reports First Quarter 2022 Results
May 09, 2022
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco and Royal DSM Announce Strategic Alliance in U.S. for Bovaer® – A Revolutionary, Methane-Reducing Feed Product for Cattle
April 27, 2022
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco Confirms Date and Conference Call for First Quarter 2022 Financial Results Announcement
April 14, 2022
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco Breaks Ground on State-of-the-Art Campus, Creating Indianapolis’ Newest Landmark
April 12, 2022
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco Animal Health Incorporated Announces Early Results of Tender Offer and Increase in Tender Cap for 2023 Notes
April 12, 2022
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco Animal Health Incorporated Announces Tender Offer for 2023 Notes
March 29, 2022
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco Expands Commitment to Creating Shared Value, Launches New Initiative Empowering Small-Scale Producers in Sub-Saharan Africa
March 16, 2022
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco Animal Health Reports Fourth Quarter and Full Year 2021 Results
February 24, 2022
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco Announces the Addition of Rajeev (Bobby) Modi to Lead U.S. Pet Health
February 22, 2022
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco to Participate in the Cowen 42nd Annual Health Care Conference
February 21, 2022
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco Adds New Tools to Advance U.S. Livestock Sustainability Efforts
February 07, 2022
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco to Participate in the BofA Securities 2022 Virtual Animal Health Summit
February 04, 2022
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2021 Financial Results Announcement
February 03, 2022
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco’s ZORBIUM™ (Buprenorphine Transdermal Solution) – the First Long-Acting Transdermal Buprenorphine for Cats - Gains U.S. Approval
January 20, 2022
From
Elanco Animal Health Incorporated
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.